Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis
Status:
Terminated
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This study will characterize the steady state pharmacokinetics of sulfasalazine delayed
release tablets in pediatric Juvenile Idiopathic Arthritis patients. Data from this study
will fulfill the post approval commitment to the FDA.